JPAD-Journal of Prevention of Alzheimers Disease

Scope & Guideline

Leading the Charge in Alzheimer’s Prevention Strategies

Introduction

Welcome to the JPAD-Journal of Prevention of Alzheimers Disease information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JPAD-Journal of Prevention of Alzheimers Disease, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2274-5807
PublisherSPRINGER BASEL AG
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJPAD-J PREV ALZHEIM / JPAD-J. Prev. Alzheimers Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPICASSOPLATZ 4, BASEL 4052, SWITZERLAND

Aims and Scopes

The Journal of Prevention of Alzheimer's Disease (JPAD) is dedicated to advancing the understanding and prevention of Alzheimer's disease through comprehensive research that encompasses a range of biological, psychological, and social factors. The journal focuses on innovative methodologies and interdisciplinary approaches to address the complexities of Alzheimer's disease and cognitive decline.
  1. Prevention Strategies and Interventions:
    The journal emphasizes the development and evaluation of various prevention strategies aimed at delaying or preventing cognitive decline and Alzheimer's disease. This includes lifestyle modifications, dietary interventions, and community-based programs.
  2. Biomarkers and Diagnostic Tools:
    Research on biomarkers for early detection and diagnosis of Alzheimer's disease is a core focus. This includes studies on blood, imaging, and genetic biomarkers that can help identify individuals at risk and monitor disease progression.
  3. Cognitive Function Assessment:
    JPAD publishes studies that explore cognitive assessments and their relevance in clinical and community settings. This includes the validation of new cognitive tests and the use of digital tools to evaluate cognitive function.
  4. Health Equity and Access:
    The journal addresses disparities in Alzheimer's disease research and treatment, focusing on recruitment strategies for underrepresented populations in clinical trials and the role of social determinants of health.
  5. Innovative Therapeutic Approaches:
    Research into new therapeutic strategies, including pharmacological and non-pharmacological interventions, is a significant area of interest. This includes studies on the efficacy of new drugs, dietary supplements, and lifestyle changes.
  6. Longitudinal Studies and Cohort Analyses:
    JPAD often features longitudinal studies that track cognitive decline over time, providing insights into the progression of Alzheimer's disease and associated risk factors.
The Journal of Prevention of Alzheimer's Disease is witnessing a dynamic shift towards several emerging themes that reflect current trends in Alzheimer's research. These themes highlight innovative approaches and interdisciplinary research efforts.
  1. Digital Health Interventions:
    The use of digital technologies for cognitive assessments, monitoring, and interventions is rapidly gaining traction. Research exploring how mobile applications and online platforms can enhance cognitive health is increasingly prevalent.
  2. Personalized Medicine Approaches:
    There is a growing emphasis on personalized medicine in Alzheimer's research, with studies focusing on tailoring interventions based on individual genetic, lifestyle, and health profiles.
  3. Multidomain Lifestyle Interventions:
    Research on multidomain interventions that combine dietary, physical, and cognitive activities to prevent cognitive decline is on the rise, reflecting an integrated approach to Alzheimer's prevention.
  4. Community Engagement in Research:
    The journal is increasingly highlighting the importance of community engagement in Alzheimer's research, particularly in recruiting diverse populations for clinical trials and addressing health disparities.
  5. Neuroinflammation and Immune Response:
    Emerging research into the role of neuroinflammation and the immune response in Alzheimer's disease is gaining prominence, with studies investigating therapeutic strategies targeting these pathways.
  6. Social Determinants of Health:
    There is an increasing focus on how social determinants, such as socioeconomic status and access to care, impact cognitive health and the progression of Alzheimer's disease.

Declining or Waning

While the Journal of Prevention of Alzheimer's Disease continues to evolve, certain themes have shown a decline in prominence in recent publications. These waning scopes suggest a shift in research priorities and emerging areas of focus.
  1. Historical Epidemiological Studies:
    There has been a noticeable decrease in the publication of traditional epidemiological studies that solely focus on historical data without integrating contemporary methods or innovative approaches.
  2. Single-Factor Risk Assessments:
    Research solely emphasizing single-factor risk assessments for Alzheimer's disease is declining. The trend is moving towards multifactorial approaches that consider a combination of genetic, environmental, and lifestyle factors.
  3. Basic Science Research:
    Studies focused exclusively on basic biological mechanisms of Alzheimer's disease without practical implications for prevention or intervention are becoming less frequent, as the journal emphasizes translational research.
  4. Pharmacological Monotherapy Trials:
    There is a waning interest in studies that evaluate the effectiveness of pharmacological monotherapies for Alzheimer's treatment, as the focus shifts towards combination therapies and holistic approaches.

Similar Journals

Psychogeriatrics

Bridging gaps in geriatric psychiatry knowledge.
Publisher: WILEYISSN: 1346-3500Frequency: 4 issues/year

Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.

Aging Brain

Connecting Research to Enhance Brain Health
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

Aging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Advancing mental health research for aging populations.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

Aktualnosci Neurologiczne

Connecting Global Minds in Neurology
Publisher: MEDICAL COMMUNICATIONSISSN: 1641-9227Frequency: 4 issues/year

Aktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.

GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry

Empowering Research for a Healthier Aging Population
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 1662-9647Frequency: 4 issues/year

GeroPsych - The Journal of Gerontopsychology and Geriatric Psychiatry, published by HOGREFE AG, stands as an essential academic resource in the evolving fields of gerontology and geriatric psychiatry. With a commitment to advancing the understanding of psychological well-being in older adults, the journal provides a platform for high-quality research, discussion, and innovation that caters to researchers, practitioners, and students alike. Although currently not an open-access publication, GeroPsych ensures accessibility through various academic libraries and institutions, fostering a collaborative approach to the complexities of aging and mental health. Recognized within the Q3 category for Geriatrics and Gerontology, and with its impact reflected in Scopus rankings, this journal plays a pivotal role in informing best practices and shaping policies within the interdisciplinary landscape of geriatric care. Spanning research from 2010 to 2024, GeroPsych is positioned as a leading journal for those committed to improving the mental health and psychological resilience of the aging population.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Pioneering Research in Neuropsychiatric Disorders
Publisher: AMER PSYCHIATRIC PUBLISHING, INCISSN: 0895-0172Frequency: 4 issues/year

The JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, published by AMER PSYCHIATRIC PUBLISHING, INC, stands as a pivotal resource in the interdisciplinary fields of psychiatry, neurology, and mental health. With a history spanning from 1989 to 2024, this esteemed journal, identified by the ISSN 0895-0172 and E-ISSN 1545-7222, provides a platform for cutting-edge research and clinical insights into neuropsychiatric disorders. As of 2023, the journal is recognized in Q2 quartiles for Medicine (miscellaneous), Neurology (clinical), and Psychiatry and Mental Health, showcasing its significant impact within these domains, as evidenced by its Scopus rankings placing it in the 67th and 65th percentiles respectively. The journal emphasizes the importance of advancing knowledge through empirical studies, case reports, and reviews, making it an invaluable asset for researchers, clinicians, and students dedicated to understanding the complexities of the human brain and its psychological manifestations. Although the journal does not currently offer open access, it remains essential for those seeking to stay at the forefront of neuropsychiatric advancements.

Neurodegenerative Disease Management

Fostering Collaboration to Combat Neurodegeneration
Publisher: FUTURE MEDICINE LTDISSN: 1758-2024Frequency: 6 issues/year

Neurodegenerative Disease Management is a distinguished journal published by FUTURE MEDICINE LTD, focusing on the pivotal issues surrounding the management of neurodegenerative diseases. Since its inception in 2014, this journal has emerged as a significant resource within the fields of medicine and neurology, currently holding a respected position with a Q2 category ranking in Medicine (miscellaneous) and Q3 in Neurology (clinical) for 2023. With an ISSN of 1758-2024 and E-ISSN 1758-2032, the journal provides a platform for the dissemination of innovative research, clinical practices, and advancements in treatment strategies for conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. The journal is particularly committed to enhancing knowledge sharing among researchers, health professionals, and students, contributing to the collective effort in combatting neurodegenerative diseases. Though not open access, its articles are meticulously curated to ensure high-quality, impactful contributions to the field, making it an essential reference for those engaged in neurology and related disciplines.

JOURNAL OF ALZHEIMERS DISEASE

Empowering professionals with cutting-edge research.
Publisher: IOS PRESSISSN: 1387-2877Frequency: 24 issues/year

Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.

Psychiatry Investigation

Exploring Innovative Solutions in Psychiatry
Publisher: KOREAN NEUROPSYCHIATRIC ASSOCISSN: 1738-3684Frequency: 12 issues/year

Psychiatry Investigation is a prominent, peer-reviewed journal published by the Korean Neuropsychiatric Association, focusing on advancements in the fields of psychiatry and mental health. With an ISSN of 1738-3684 and an E-ISSN of 1976-3026, this journal has steadily gained recognition within the academic community since its inception in 2006. Spanning a dynamic spectrum of research topics, it aims to disseminate innovative findings and facilitate discussions that contribute to the understanding and treatment of psychiatric disorders. As evidenced by its current Scopus rankings—positioned in the Q2 category for Psychiatry and Mental Health and the Q3 category for Biological Psychiatry—the journal is committed to maintaining high scholarly standards and impactful research contributions. Although fully open access is not available, the relevance of its content ensures that it remains a critical resource for researchers, clinicians, and students alike, furthering knowledge and practices in the field of mental health.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Championing evidence-based practices in Alzheimer’s research.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0893-0341Frequency: 4 issues/year

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.